The link between blood pressure and Alzheimer's disease

Affiliations

Comment

Charles DeCarli. Lancet Neurol. 2021 Nov.

. 2021 Nov;20(11):878-879.

doi: 10.1016/S1474-4422(21)00340-9.

¹ Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, CA 95817, USA. Electronic address: cdecarli@ucdavis.edu.

No abstract available

Conflict of interest statement

I declare no competing interests.

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators. Kehoe PG, et al. Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5. Lancet Neurol. 2021. PMID: 34687634 Free PMC article. Clinical Trial.